Testing effectiveness (Phase 2)WithdrawnNCT05393999
What this trial is testing
SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations
Who this might be right for
SARS-CoV2 InfectionSARS-CoV-2 Acute Respiratory DiseaseMyeloma+4 more
Imperial College Healthcare NHS Trust